IVP · As filed with the SEC
Inspire Veterinary Partners income statement, by fiscal year
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD, except per-share amounts
| USD, except per-share amounts | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|
| Total revenue | 16,592,109 | — | — |
| Service Revenue | 12,188,526 | — | — |
| Product Revenue | 4,403,583 | — | — |
| Operating expenses | |||
| Service | — | 9,700,963 | 5,308,104 |
| Product | — | 3,420,515 | 1,981,046 |
| Cost of Service Revenue | 9,736,282 | — | — |
| Cost of Product Revenue | 3,563,279 | — | — |
| General and administrative expenses | 11,421,352 | 9,476,287 | 5,467,642 |
| Depreciation and amortization | 1,308,619 | 1,252,539 | 596,124 |
| Impairment expense | 56,664 | — | — |
| Gain on sale of business | (467,049) | — | — |
| Total operating expenses | 25,619,147 | 23,866,409 | 13,352,916 |
| Loss from operations | (9,027,038) | (7,191,016) | (3,518,138) |
| Other income (expenses): | |||
| Interest income | 53 | 21 | 1,021 |
| Interest expense | (3,098,290) | (2,538,710) | (1,425,260) |
| Loss on debt extinguishment | — | 16,105 | — |
| Loss on debt modification | (2,134,218) | (927,054) | — |
| Beneficial conversion feature | — | (4,137,261) | — |
| Other income (expenses) | (4,768) | 1,134 | 357 |
| Total other expenses | (5,237,223) | (7,601,870) | (1,423,882) |
| Loss before income taxes | (14,264,261) | (14,792,886) | (4,942,020) |
| Benefit for income taxes | — | — | 30,094 |
| Net loss | (14,264,261) | (14,792,886) | (4,911,926) |
| Dividend on convertible series A preferred stock | (220,850) | (271,245) | — |
| Net loss attributable to class A and B common stockholders | (14,485,111) | (15,064,131) | (4,911,926) |
| Net loss per Class A and B common shares: | |||
| Class A and B Common Shares | (2.61) | (2.25) | (0.95) |
| Class A and B Common Shares | (2.61) | — | — |
| Weighted average shares outstanding per Class A and B common shares: | |||
| Class A and B Common Shares | 5,550,959 | 6,692,515 | 5,160,182 |
| Class A and B Common Shares | 5,550,959 | — | — |
| Total revenue | — | 16,675,393 | 9,834,778 |
| Service | — | 11,879,934 | 7,032,800 |
| Product | — | 4,795,459 | 2,801,978 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.